Literature DB >> 6757811

Indolealkylamine and phenalkylamine hallucinogens: a brief overview.

R A Glennon, J A Rosecrans.   

Abstract

Various indolealkylamine and phenalkylamine derivatives are hallucinogenic in man and/or are behaviorally active in animals. This overview is divided into two parts. The first part attempts to bring together information concerning the activity of indolealkylamines (i.e., tryptamines, alpha-methyltryptamines, N,N-dimethyltryptamines, N-alkyltryptamines, lysergic acid derivatives and beta-carbolines) and phenalkylamines (i.e., phenethylamines, phenylisopropylamines) along with major key references, and with emphasis on those agents not recently reviewed. The latter portion of this overview describes some of the work being conducted in our laboratories in an effort to elucidate the role of the neurotransmitter serotonin in the mechanism of action of various indolealkylamine and phenalkylamine hallucinogens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757811     DOI: 10.1016/0149-7634(82)90030-6

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  7 in total

1.  The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.

Authors:  Kirsten Krebs-Thomson; Erbert M Ruiz; Virginia Masten; Mahalah Buell; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2006-09-30       Impact factor: 4.530

2.  Modification of voltage-dependent gating of potassium channels by free form of tryptophan side chain.

Authors:  V Avdonin; T Hoshi
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

3.  The rise (and fall?) of drug discrimination research.

Authors:  Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2015-06-01       Impact factor: 4.492

4.  Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.

Authors:  P A Pierce; S J Peroutka
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice.

Authors:  Adam L Halberstadt; Susan B Powell; Mark A Geyer
Journal:  Neuropharmacology       Date:  2013-01-29       Impact factor: 5.250

Review 6.  Clinical features and management of intoxication due to hallucinogenic drugs.

Authors:  J B Leikin; A J Krantz; M Zell-Kanter; R L Barkin; D O Hryhorczuk
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

Review 7.  1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Authors:  Sylvana Vilca-Melendez; Malin V Uthaug; Julian L Griffin
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.